FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch

[cafead]

via A multiple sclerosis drug that came to Bristol Myers Squibb via its acquisition of Celgene last year was approved Thursday but don’t expect it to reach patients any time soon. The company says the drug’s launch will be delayed due to the coronavirus pandemic.

article source